Lin Jing-Yu, Cheng Jie, Du Ya-Qin, Pan Wei, Zhang Zhong, Wang Jin, An Jie, Yang Fan, Xu Yun-Fei, Lin Hui, An Wen-Tao, Wang Jia, Yang Zhao, Chai Ren-Jie, Sha Xue-Ying, Hu Hui-Li, Sun Jin-Peng, Yu Xiao
1Key Laboratory Experimental Teratology of the Ministry of Education and Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Shandong University, 250012 Jinan, Shandong China.
Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, 100191 Beijing, China.
Cell Discov. 2020 Apr 7;6:20. doi: 10.1038/s41421-020-0159-x. eCollection 2020.
Tissue regeneration, such as pancreatic islet tissue propagation in vitro, could serve as a promising strategy for diabetes therapy and personalised drug testing. However, such a strategy has not been realised yet. Propagation could be divided into two steps, in vitro expansion and repeated passaging. Even the first step of the in vitro islet expansion has not been achieved to date. Here, we describe a method that enables the expansion of islet clusters isolated from pregnant mice or wild-type rats by employing a combination of specific regeneration factors and chemical compounds in vitro. The expanded islet clusters expressed insulin, glucagon and somatostatin, which are markers corresponding to pancreatic β cells, α cells and δ cells, respectively. These different types of cells grouped together, were spatially organised and functioned similarly to primary islets. Further mechanistic analysis revealed that forskolin in our recipe contributed to renewal and regeneration, whereas exendin-4 was essential for preserving islet cell identity. Our results provide a novel method for the in vitro expansion of islet clusters, which is an important step forward in developing future protocols and media used for islet tissue propagation in vitro. Such method is important for future regenerative diabetes therapies and personalised medicines using large amounts of pancreatic islets derived from the same person.
组织再生,如体外胰岛组织增殖,可作为糖尿病治疗和个性化药物测试的一种有前景的策略。然而,这种策略尚未实现。增殖可分为两个步骤,即体外扩增和反复传代。到目前为止,即使是体外胰岛扩增的第一步也尚未实现。在此,我们描述了一种方法,该方法通过在体外使用特定的再生因子和化合物组合,能够扩增从怀孕小鼠或野生型大鼠分离的胰岛簇。扩增后的胰岛簇表达胰岛素、胰高血糖素和生长抑素,它们分别是对应于胰腺β细胞、α细胞和δ细胞的标志物。这些不同类型的细胞聚集在一起,在空间上有组织地排列,并且功能与原代胰岛相似。进一步的机制分析表明,我们配方中的福司可林有助于更新和再生,而艾塞那肽-4对于维持胰岛细胞特性至关重要。我们的结果提供了一种体外扩增胰岛簇的新方法,这是在开发未来用于体外胰岛组织增殖的方案和培养基方面向前迈出的重要一步。这种方法对于未来使用来自同一个人的大量胰岛进行再生糖尿病治疗和个性化药物至关重要。